In meningiomas, in addition to histopathological features, alterations in NF2, AKT1, TRAF7, SMO, PIK3CA, KLF4, and SMARCE1 genes are recognised as key biomarkers in molecular classification [8,9]. This evidence concerns the gene AKT1 and meningioma.